Women's Health MRI

Use of the glucagon receptor/glucagon-like peptide-1 receptor dual agonist survodutide led to a > 30 percent reduction in liver fat content in nearly 85 percent of obese patients with at-risk MASLD, according to MRI findings in new phase 3 research.

Catch up on a variety of new FDA clearances in radiology from the past week.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in May 2026.

In a study of 351 women with BI-RADS 3-5 non-mass enhancement breast lesions, researchers found that multiparametric MRI offered 98.4 percent sensitivity and a 97.9 percent negative predictive value (NPV).

In a new meta-analysis examining the impact of MRI-based AI models for predicting high-grade hepatocellular carcinoma, researchers noted a 10 percent decline in AUC between internal validation and external validation.

The combination of sustained high-gradient performance and AI capabilities with the Titanion MR may facilitate the use of imaging biomarkers that provide insight into tissue microstructure

Cystadenomas and cystadenofibromas accounted for 46 percent of benign lesions initially scored as O-RADS 4 and 5 lesions on pelvic ultrasound, according to newly published research.

Increased paraspinal intermuscular adipose tissue (IMAT) on whole-body MRI was associated with a 67 percent higher likelihood of hypertension, according to new research involving over 11,300 participants without preexisting conditions.

Emerging MRI findings from phase 3 research revealed that over 28 percent of patients with perianal fistulizing Crohn’s disease achieved combined fistula remission 24 weeks after initiating treatment with the IL-23 inhibitor guselkumab.

In a recent interview with Diagnostic Imaging, Wendie Berg, MD, PhD, shared her perspective on various aspects of the controversial breast cancer screening guidance issued by the American College of Physicians (ACP), including the use of supplemental imaging in women with dense breasts.

In a roundup of breast imaging news and research from April 2026, we take a look back at pertinent findings with AI and digital breast tomosynthesis (DBT), breast MRI studies and breast cancer screening guidelines from the National Comprehensive Cancer Network (NCCN) and the American College of Physicians (ACP).

Providing enhanced multidimensional displays of MRI and CT imaging, the Avatar Medical Vision software may facilitate improved surgical planning and intraoperative communication.

Catch up on the most-well viewed radiology content in April 2026.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on a variety of new FDA clearances in radiology from the past week.

Employing the SwiftMR software with deep learning reconstruction solutions from original equipment manufacturers (OEMs) may provide additional sequence coverage as well as scan time reduction.

Catch up on the top radiology content of the past week.

In a time-independent test set from a new retrospective study, gadoxetic-acid enhanced MRI provided nearly 38 percent higher sensitivity for detecting sub-centimeter hepatocellular carcinoma recurrence (HCC) in contrast to extracellular contrast agent-enhanced MRI.

For patients with cardiac dysfunction related to neoadjuvant chemotherapy for invasive breast cancer, new MRI research shows increased risks for concurrent decreases in total brain volume and white matter volume.

The neuropacs™ MRI-based AI software provided a 96 percent or better AUROC for differentiating between Parkinson’s disease, atypical parkinsonism, multiple system atrophy Parkinsonian variant and progressive supranuclear palsy, according to a prospective multicenter study published in JAMA Neurology.

There was no statistically significant difference in sensitivity rates for lesion detection between breast MRI scans with minimum or mild background parenchymal enhancement (BPE) and those with moderate or marked BPE, according to a newly published study involving over 300 women.

A combination of time-dependent diffusion MRI-derived parameters and quantitative macromolecular proton fraction (MPF) demonstrated a 96 percent AUC for differentiating high-grade and low-grade cervical cancer, according to newly published research.

Catch up on the top radiology content of the past week.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.